Since the insulin-like growth factor receptor (IGF-1R) is overexpressed in different cancer cells [40,41,42] and the IGF-1-dependent pathway plays a major role in cancer cell proliferation, novel approaches aim to inhibit IGF-1R in cancer treatment [43]. Here, IGF1R is linked to cancer.